Demyelination: The Role of Reactive Oxygen and Nitrogen Species

This review summarises the role that reactive oxygen and nitrogen species play in demyelination, such as that occurring in the inflammatory demyelinating disorders multiple sclerosis and Guillain‐Barré syndrome. The concentrations of reactive oxygen and nitrogen species (e.g. superoxide, nitric oxide and peroxynitrite) can increase dramatically under conditions such as inflammation, and this can overwhelm the inherent antioxidant defences within lesions. Such oxidative and/or nitrative stress can damage the lipids, proteins and nucleic acids of cells and mitochondria, potentially causing cell death. Oligodendrocytes are more sensitive to oxidative and nitrative stress in vitro than are astrocytes and microglia, seemingly due to a diminished capacity for antioxidant defence, and the presence of raised risk factors, including a high iron content. Oxidative and nitrative stress might therefore result in vivo in selective oligodendrocyte death, and thereby demyelination. The reactive species may also damage the myelin sheath, promoting its attack by macrophages. Damage can occur directly by lipid peroxidation, and indirectly by the activation of proteases and phospholipase A2. Evidence for the existence of oxidative and nitrative stress within inflammatory demyelinating lesions includes the presence of both lipid and protein peroxides, and nitrotyrosine (a marker for peroxynitrite formation). The neurological deficit resulting from experimental autoimmune demyelinating disease has generally been reduced

[1]  D. Wink,et al.  Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. , 1998, Free radical biology & medicine.

[2]  Joseph J. Volpe,et al.  Maturation-Dependent Vulnerability of Oligodendrocytes to Oxidative Stress-Induced Death Caused by Glutathione Depletion , 1998, The Journal of Neuroscience.

[3]  C. Coleclough,et al.  Reciprocal stimulation between TNF-α and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis , 1998, Journal of Neuroimmunology.

[4]  W. Cowden,et al.  Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE , 1998, Journal of Neuroimmunology.

[5]  R. Schmidt,et al.  Peroxynitrite formation within the central nervous system in active multiple sclerosis , 1998, Journal of Neuroimmunology.

[6]  K. Boje,et al.  Nitric oxide and prostaglandin E2 formation parallels blood–brain barrier disruption in an experimental rat model of bacterial meningitis , 1998, Brain Research Bulletin.

[7]  D. L. Wetzel,et al.  Chemical analysis of multiple sclerosis lesions by FT-IR microspectroscopy. , 1998, Free radical biology & medicine.

[8]  J. Zweier,et al.  Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. , 1998, Archives of biochemistry and biophysics.

[9]  F. Abboud,et al.  Nitric Oxide as an Autocrine Regulator of Sodium Currents in Baroreceptor Neurons , 1998, Neuron.

[10]  S. LeVine,et al.  Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice , 1998, Journal of Neuroimmunology.

[11]  K. Frei,et al.  Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis , 1998, European Journal of Immunology.

[12]  L. Hertz,et al.  Peroxide‐scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress , 1998, Glia.

[13]  J. Connor,et al.  An in vitro model for analysis of oxidative death in primary mouse astrocytes , 1998, Brain Research.

[14]  J. Weidner,et al.  This information is current as Gene NOS 2 Exacerbated in Mice Lacking the Experimental Autoimmune Encephalomyelitis Is , 1998 .

[15]  L. Ignarro,et al.  Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice , 1998, The Journal of Immunology.

[16]  D. Mattson,et al.  Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line , 1998, Journal of Neuroimmunology.

[17]  C. Brosnan,et al.  Selective inhibition of human glial inducible nitric oxide synthase by interferon‐β: Implications for multiple sclerosis , 1998, Annals of neurology.

[18]  John C. Lee,et al.  Extracellular Signal-Regulated Kinase and p38 Subgroups of Mitogen-Activated Protein Kinases Regulate Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-α Gene Expression in Endotoxin-Stimulated Primary Glial Cultures , 1998, The Journal of Neuroscience.

[19]  G. Giovannoni Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis , 1998, Multiple sclerosis.

[20]  H. Maeda,et al.  Human Matrix Metalloprotease Activation by Insults of Bacterial Infection Involving Proteases and Free Radicals , 1998, Biological chemistry.

[21]  D. Mattson,et al.  Nerve conduction block by nitric oxide that is mediated by the axonal environment. , 1998, Journal of neurophysiology.

[22]  A. Cellerino,et al.  Free Radical Scavenging and Inhibition of Nitric Oxide Synthase Potentiates the Neurotrophic Effects of Brain-Derived Neurotrophic Factor on Axotomized Retinal Ganglion Cells In Vivo , 1998, The Journal of Neuroscience.

[23]  A. Cross,et al.  Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection , 1998, Journal of Neuroimmunology.

[24]  G. Levi,et al.  Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide , 1998, Progress in Neurobiology.

[25]  H. Koprowski,et al.  Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Heales,et al.  Pretreatment of Astrocytes with Interferon‐α/β Prevents Neuronal Mitochondrial Respiratory Chain Damage , 1998 .

[27]  R. Murphy,et al.  Free radicals in inflammatory neurological disease: Increased lipid peroxidation and haptoglobin levels in Guillain Barre syndrome , 1998, Irish journal of medical science.

[28]  L. Ignarro,et al.  Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. , 1998, Journal of immunology.

[29]  S. Heales,et al.  Pretreatment of astrocytes with interferon-alpha/beta prevents neuronal mitochondrial respiratory chain damage. , 1998, Journal of neurochemistry.

[30]  E. Pinteaux,et al.  Distribution of mitochondrial manganese superoxide dismutase among rat glial cells in culture. , 1998, Glia.

[31]  ichard,et al.  AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS , 1998 .

[32]  B. Juurlink Response of Glial Cells to Ischemia: Roles of Reactive Oxygen Species and Glutathione , 1997, Neuroscience & Biobehavioral Reviews.

[33]  Y. Ando,et al.  Changes in nitrite and nitrate (NO2 −/NO3 −) levels in cerebrospinal fluid of patients with multiple sclerosis , 1997, Journal of the Neurological Sciences.

[34]  A. Cross,et al.  Evidence for the production of peroxynitrite in inflammatory CNS demyelination , 1997, Journal of Neuroimmunology.

[35]  S. Murphy,et al.  Activated astrocytes induce nitric oxide synthase‐2 in cerebral endothelium via tumor necrosis factor α , 1997, Glia.

[36]  M. Morganti-Kossmann,et al.  Neurotransmitters in cerebrospinal fluid reflect pathological activity , 1997, European journal of clinical investigation.

[37]  J. Merrill,et al.  Inflammatory Events at the Blood Brain Barrier: Regulation of Adhesion Molecules, Cytokines, and Chemokines by Reactive Nitrogen and Oxygen Species , 1997, Brain, Behavior, and Immunity.

[38]  A. Orlacchio,et al.  Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis , 1997, Journal of Neuroimmunology.

[39]  K. Smith,et al.  Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. , 1997, Brain : a journal of neurology.

[40]  R. L. Cooper Multiple sclerosis: an immune legacy? , 1997, Medical hypotheses.

[41]  John X. Wilson,et al.  Antioxidant defense of the brain: a role for astrocytes. , 1997, Canadian journal of physiology and pharmacology.

[42]  R. Hughes,et al.  A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis. , 1997, Brain : a journal of neurology.

[43]  R. P. Kinkel,et al.  Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis , 1997, Neurology.

[44]  M. Grisham,et al.  Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. , 1997, The American journal of physiology.

[45]  M. Mckinney,et al.  Immunostimulation protects microglial cells from nitric oxide-mediated apoptosis. , 1997, Neuroreport.

[46]  Kenneth J. Smith,et al.  REVIEW ■ : Axonal Hyperexcitability: Mechanisms and Role in Symptom Production in Demyelinating Diseases , 1997 .

[47]  M. Duchen,et al.  Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system , 1997, Progress in Neurobiology.

[48]  D. Hinton,et al.  Extensive peroxynitrite activity during progressive stages of central nervous system inflammation , 1997, Journal of Neuroimmunology.

[49]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[50]  W. Mcdonald,et al.  Pretreatment of Astrocytes with Interferon‐α/β Impairs Interferon‐γ Induction of Nitric Oxide Synthase , 1997 .

[51]  J M Land,et al.  Nitric Oxide‐Mediated Mitochondrial Damage in the Brain: Mechanisms and Implications for Neurodegenerative Diseases , 1997, Journal of neurochemistry.

[52]  D D Breimer,et al.  The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.

[53]  C. Lowenstein,et al.  Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes , 1997, Journal of neuroscience research.

[54]  I. Singh,et al.  Modulation of Endogenous Antioxidant Enzymes by Nitric Oxide in Rat C6 Glial Cells , 1997 .

[55]  G S Scott,et al.  Reactive oxygen species in experimental allergic encephalomyelitis. , 1997, Biochemical Society transactions.

[56]  S. Schwab,et al.  Suppression of the oxidative burst in murine microglia by nitric oxide , 1997, Neuroscience Letters.

[57]  Y. Vodovotz,et al.  Superoxide Modulates the Oxidation and Nitrosation of Thiols by Nitric Oxide-derived Reactive Intermediates , 1997, The Journal of Biological Chemistry.

[58]  G. Tocco,et al.  Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. , 1997, Cellular immunology.

[59]  G. FitzGerald,et al.  Urinary 8-EPI PGF2α: an index of oxidant stress in vivo* , 1997 .

[60]  Y.-G. Li,et al.  Slow sodium-dependent potential oscillations contribute to ectopic firing in mammalian demyelinated axons. , 1997, Brain : a journal of neurology.

[61]  O. Bagasra,et al.  Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. Sobel,et al.  Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. , 1997, Journal of immunology.

[63]  D. Grzybicki,et al.  Nitric oxide synthase Type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection , 1997, Journal of Neuroimmunology.

[64]  A. van Dam,et al.  Inhibition of endotoxin‐induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: A role for transforming growth factor β , 1997 .

[65]  J. Merrill,et al.  The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.

[66]  G. Levi,et al.  Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors , 1997, Glia.

[67]  G. Juhász,et al.  Amino acid concentrations in cerebrospinal fluid of patients with multiple sclerosis , 1997, Acta neurologica Scandinavica.

[68]  C. D. DE GROOT,et al.  Immunocytochemical Characterization of the Expression of Inducible and Constitutive Isoforms of Nitric Oxide Synthase in Demyelinating Multiple Sclerosis Lesions , 1997, Journal of neuropathology and experimental neurology.

[69]  S. Baig,et al.  Neurotoxicity and possible roles of aspartic acid, glutamic acid and GABA in some neurologic disorders , 1997 .

[70]  K. Scharffetter-Kochanek,et al.  Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. , 1997, Free radical biology & medicine.

[71]  W. Mcdonald,et al.  Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase. , 1997, Journal of neurochemistry.

[72]  C. Szabó Physiological and pathophysiological roles of nitric oxide in the central nervous system , 1996, Brain Research Bulletin.

[73]  A. Cross,et al.  Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis , 1996, Journal of Neuroimmunology.

[74]  G. Kroemer,et al.  Mitochondrial permeability transition triggers lymphocyte apoptosis. , 1996, Journal of immunology.

[75]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[76]  D. Wink,et al.  Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage. , 1996, Carcinogenesis.

[77]  C. Brosnan,et al.  Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist. , 1996, Journal of immunology.

[78]  H. Link,et al.  The cerebrospinal fluid from patients with multiple sclerosis promotes neuronal and oligodendrocyte damage by delayed production of nitric oxide in vitro , 1996, Journal of the Neurological Sciences.

[79]  H. Sontheimer,et al.  Cytokine modulation of glial glutamate uptake: a possble involvement of nitric oxide , 1996, Neuroreport.

[80]  N. Janabi,et al.  Endogenous nitric oxide activates prostaglandin F2 alpha production in human microglial cells but not in astrocytes: a study of interactions between eicosanoids, nitric oxide, and superoxide anion (O2-) regulatory pathways. , 1996, Journal of immunology.

[81]  B. Juurlink,et al.  Low Glutathione and High Iron Govern the Susceptibility of Oligodendroglial Precursors to Oxidative Stress , 1996, Journal of neurochemistry.

[82]  S. Back,et al.  Cystine Deprivation Induces Oligodendroglial Death: Rescue by Free Radical Scavengers and by a Diffusible Glial Factor , 1996, Journal of neurochemistry.

[83]  M. Aschner The functional significance of brain metallothioneins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[84]  S. Snyder,et al.  Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Bockaert,et al.  Effects of nitric oxide on glutamate-gated channels and other ionic channels , 1996, Journal of Chemical Neuroanatomy.

[86]  J. Neal,et al.  Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain , 1996, Neuropathology and applied neurobiology.

[87]  R. J. Waugh,et al.  Mass spectrometric analysis of four regioisomers of F2-isoprostanes formed by free radical oxidation of arachidonic acid , 1996, Journal of the American Society for Mass Spectrometry.

[88]  C. Colton,et al.  Species differences in the generation of reactive oxygen species by microglia , 1996, Molecular and chemical neuropathology.

[89]  John X. Wilson,et al.  Osmotic Swelling Stimulates Ascorbate Efflux from Cerebral Astrocytes , 1996, Journal of neurochemistry.

[90]  S. Linden,et al.  Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors , 1996, Clinical and experimental immunology.

[91]  S. Barnes,et al.  Peroxynitrite-dependent tryptophan nitration. , 1996, Chemical research in toxicology.

[92]  H. Hartung,et al.  Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro. , 1996, Cellular immunology.

[93]  A. Compston,et al.  Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. , 1996, Brain : a journal of neurology.

[94]  M. Mcdaniel,et al.  Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase , 1996, Journal of Neuroimmunology.

[95]  T. Olsson,et al.  Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. , 1996, Brain : a journal of neurology.

[96]  S. Baig,et al.  Multiple sclerosis and neurotransmission , 1996 .

[97]  C. Szabó,et al.  DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. , 1996, Free radical biology & medicine.

[98]  F. J. Romero Antioxidants in peripheral nerve. , 1996, Free radical biology & medicine.

[99]  D. Muller,et al.  Lipid peroxidation in neural tissues and fractions from vitamin E-deficient rats. , 1996, Free radical biology & medicine.

[100]  M. Reilly,et al.  8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. , 1996, British journal of clinical pharmacology.

[101]  E. Kinnunen [Beta interferon and multiple sclerosis]. , 1996, Duodecim; laaketieteellinen aikakauskirja.

[102]  T. Dawson,et al.  Neurobiology of nitric oxide. , 1996, Critical reviews in neurobiology.

[103]  J. Bolaños,et al.  Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. , 1996, Free radical biology & medicine.

[104]  J. Beckman,et al.  The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. , 1996, Advances in experimental medicine and biology.

[105]  O. Bagasra,et al.  Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[106]  S. Chandler,et al.  Matrix metalloproteinases degrade myelin basic protein , 1995, Neuroscience Letters.

[107]  Shuxian Hu,et al.  Differential regulation by cytokines of human astrocyte nitric oxide production , 1995, Glia.

[108]  M. D. Mossalayi,et al.  Nitric oxide production by human monocytes: evidence for a role of CD23. , 1995, Immunology today.

[109]  M. Colasanti,et al.  Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor α stimulation , 1995, Neuroscience Letters.

[110]  B. Juurlink,et al.  Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species , 1995, Brain Research.

[111]  D. Grzybicki,et al.  Activation of Astrocytes in the Spinal Cord of Mice Chronically Infected with a Neurotropic Coronavirus , 1995, Virology.

[112]  S. Sakoda,et al.  Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis , 1995, Journal of Neuroimmunology.

[113]  L. A. Hansen,et al.  Suppression of hyperacute and passively transferred experimental autoimmune encephalomyelitis by the anti-oxidant, butylated hydroxyanisole , 1995, Journal of Neuroimmunology.

[114]  Sean Murphy,et al.  Expression of Inducible Nitric Oxide Synthase in Cerebral Endothelial Cells Is Regulated by Cytokine‐Activated Astrocytes , 1995, Journal of neurochemistry.

[115]  M. Ikeda,et al.  Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome. , 1995, Internal medicine.

[116]  G. Kroemer,et al.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death , 1995, The Journal of experimental medicine.

[117]  J. Bolaños,et al.  Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration , 1995, Neuroscience Letters.

[118]  Keij Suzuki,et al.  Immunochemical detection of metallothionein in brain , 1995, Neurochemistry International.

[119]  G. Andrews,et al.  Temporalspatial patterns of expression of metallothionein-I and -III and other stress related genes in rat brain after kainic acid-induced seizures , 1995, Neurochemistry International.

[120]  M. Geffard,et al.  Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine , 1995, Journal of Neuroimmunology.

[121]  P. Iversen,et al.  Expression and regulation of brain metallothionein , 1995, Neurochemistry International.

[122]  J. Wilson,et al.  Ascorbate Transport and Intracellular Concentration in Cerebral Astrocytes , 1995, Journal of neurochemistry.

[123]  H. Koprowski,et al.  Local nitric oxide production in viral and autoimmune diseases of the central nervous system. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[124]  E. Bongarzone,et al.  Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species , 1995, Journal of neuroscience research.

[125]  H. Kolb,et al.  Suppression of nitric oxide toxicity in islet cells by α‐tocopherol , 1995 .

[126]  S. Hirai,et al.  Activated microglia cause superoxide-mediated release of iron from ferritin , 1995, Neuroscience Letters.

[127]  C. Raine,et al.  The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.

[128]  T. Billiar Nitric Oxide Novel Biology with Clinical Relevance , 1995, Annals of surgery.

[129]  H. Hartung,et al.  Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis , 1995, Journal of Neuroimmunology.

[130]  H. Vinters,et al.  Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes , 1995, Neuroscience.

[131]  F. Hofmann,et al.  Functional consequences of sulfhydryl modification in the pore-forming subunits of cardiovascular Ca2+ and Na+ channels. , 1995, Circulation research.

[132]  F. Abboud,et al.  Modulation of baroreceptor activity by nitric oxide and S-nitrosocysteine. , 1995, Circulation research.

[133]  C. Piantadosi,et al.  Hydroxyl radical production in the brain after CO hypoxia in rats. , 1995, Free radical biology & medicine.

[134]  Christine D. Dijkstra,et al.  Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats , 1995, Journal of Neuroimmunology.

[135]  H. Reichmann,et al.  Inhibition of brain macrophage/microglial respiratory chain enzyme activity in experimental autoimmune encephalomyelitis of the Lewis rat , 1995, Neuroscience Letters.

[136]  S. Snyder,et al.  Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase , 1995, Annals of neurology.

[137]  J. Bolaños,et al.  Evidence for increased nitric oxide production in multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[138]  C. Colton Induction of nitric oxide in cultured microglia: evidence for a cytoprotective role. , 1995, Advances in neuroimmunology.

[139]  H. Kolb,et al.  Suppression of nitric oxide toxicity in islet cells by alpha-tocopherol. , 1995, FEBS letters.

[140]  J Garthwaite,et al.  Nitric oxide signaling in the central nervous system. , 1995, Annual review of physiology.

[141]  C. Rice-Evans,et al.  Chapter 5 – Formation of free radicals and mechanisms of action in normal biochemical processes and pathological states , 1994 .

[142]  L. Steinman,et al.  Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. , 1994, The Journal of clinical investigation.

[143]  D. Hanley,et al.  Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.

[144]  C. Colton,et al.  Induction of Superoxide Anion and Nitric Oxide Production in Cultured Microglia a , 1994, Annals of the New York Academy of Sciences.

[145]  S. Barnes,et al.  Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. , 1994, The Journal of biological chemistry.

[146]  G. F. Weber The pathophysiology of reactive oxygen intermediates in the central nervous system. , 1994, Medical hypotheses.

[147]  M. Jensen,et al.  Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis , 1994, Journal of Neuroimmunology.

[148]  J. Bolaños,et al.  Nitric Oxide‐Mediated Inhibition of the Mitochondrial Respiratory Chain in Cultured Astrocytes , 1994, Journal of neurochemistry.

[149]  T. Olsson,et al.  Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis , 1994, Annals of neurology.

[150]  M. Noble,et al.  N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[151]  L. Ignarro,et al.  Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cellsin vitro , 1994, Neuroscience.

[152]  J. Springfield,et al.  Pitfalls in the use of breath pentane measurements to assess lipid peroxidation. , 1994, Journal of lipid research.

[153]  S. Hirai,et al.  Detection of Superoxide Production by Activated Microglia Using a Sensitive and Specific Chemiluminescence Assay and Microglia‐Mediated PC12h Cell Death , 1994, Journal of neurochemistry.

[154]  D. Troost,et al.  Localization of metallothionein in the mammalian central nervous system. , 1994, Biological signals.

[155]  S. Murphy,et al.  Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells. , 1994, Biochemical and biophysical research communications.

[156]  C. Colton,et al.  K+ modulation of microglial superoxide production: involvement of voltage-gated Ca2+ channels. , 1994, The American journal of physiology.

[157]  A. Cross,et al.  Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. , 1994, The Journal of clinical investigation.

[158]  C. Nathan,et al.  Regulation of biosynthesis of nitric oxide. , 1994, The Journal of biological chemistry.

[159]  R. Cohen,et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.

[160]  A. Taylor-Robinson,et al.  Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.

[161]  J. Newcombe,et al.  Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis , 1994, Neuropathology and applied neurobiology.

[162]  J. Antel,et al.  Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes , 1994, Brain Research.

[163]  W. Brück,et al.  Oligodendrocytes in the early course of multiple sclerosis , 1994, Annals of neurology.

[164]  J. Connor,et al.  Iron acquisition and expression of iron regulatory proteins in the developing brain: manipulation by ethanol exposure, iron deprivation and cellular dysfunction. , 1994, Developmental neuroscience.

[165]  A. Casadevall,et al.  Reactive nitrogen intermediates in human neuropathology: an overview. , 1994, Developmental neuroscience.

[166]  S. McGorray,et al.  Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis. , 1994, Ophthalmic research.

[167]  V. Calabrese,et al.  Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. , 1994, International journal of clinical pharmacology research.

[168]  J. Chen,et al.  Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. , 1994, Progress in brain research.

[169]  Kenneth J. Smith Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders , 1994, Eye.

[170]  R. Gopalakrishna,et al.  Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. , 1993, The Journal of biological chemistry.

[171]  M. Mcdaniel,et al.  Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes , 1993, Neuroscience Letters.

[172]  K. Miura,et al.  Maintenance of Neuronal Glutathione by Glial Cells , 1993, Journal of neurochemistry.

[173]  James B. Mitchell,et al.  Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[174]  G. Opdenakker,et al.  Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein , 1993, Journal of neuroscience research.

[175]  W. Halliday,et al.  Infrared spectroscopic characterisation of multiple sclerosis plaques in the human central nervous system. , 1993, Biochimica et biophysica acta.

[176]  Balaraman Kalyanaraman,et al.  Peroxynitrite modification of low‐density lipoprotein leads to recognition by the macrophage scavenger receptor , 1993, FEBS letters.

[177]  G. Bartosz,et al.  Increased generation of superoxide radicals in the blood of MS patients , 1993, Acta neurologica Scandinavica.

[178]  L. Ignarro,et al.  Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. , 1993, Journal of immunology.

[179]  C. Hutter On the causes of multiple sclerosis. , 1993, Medical hypotheses.

[180]  W. Fiers,et al.  Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene‐inductive effects of TNF. , 1993, The EMBO journal.

[181]  Y. Vodovotz,et al.  Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta , 1993, The Journal of experimental medicine.

[182]  A. Cross,et al.  Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study , 1993, The Journal of experimental medicine.

[183]  S. Murphy,et al.  Cytokines Regulate L‐Arginine‐Dependent Cyclic GMP Production in Rat Glial Cells , 1993, The European journal of neuroscience.

[184]  H. Hartung,et al.  Tumor necrosis factor-α in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system , 1993, Journal of Neuroimmunology.

[185]  S. Bondy,et al.  The relationship between excitotoxicity and oxidative stress in the central nervous system. , 1993, Free radical biology & medicine.

[186]  D. Troost,et al.  Distribution of metallothionein in the human central nervous system , 1993, Glia.

[187]  C. Raine,et al.  Multiple Sclerosis: Remyelination in Acute Lesions , 1993, Journal of neuropathology and experimental neurology.

[188]  J. Volpe,et al.  Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[189]  L. Rorke,et al.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[190]  C. Damais,et al.  IL1 and TNFα induce cGMP formation in C6 astrocytoma cells via the nitridergic pathway , 1993, Brain Research.

[191]  G. Nisticó,et al.  Cytokine-induced nitric oxide generation by cultured astrocytoma cells involves Ca(++)-calmodulin-independent NO-synthase. , 1993, Biochemical and biophysical research communications.

[192]  J. Sawada,et al.  Induction of metallothionein in a human astrocytoma cell line by interleukin‐1 and heavy metals , 1993, FEBS letters.

[193]  E. Cho,et al.  Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .

[194]  D. Kirschner,et al.  Thioridazine induces lipid peroxidation in myelin of rat brain , 1993, Neuropharmacology.

[195]  S. Baig,et al.  Role of neurotransmitter amino acids in multiple sclerosis in exacerbation, remission and chronic progressive course , 1993 .

[196]  E. Cho,et al.  Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.

[197]  M. Mcdaniel,et al.  Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. , 1993, Neuroscience letters.

[198]  J. Guy,et al.  Role of hydrogen peroxide in experimental optic neuritis. A serial quantitative ultrastructural study. , 1993, Ophthalmic research.

[199]  C. Damais,et al.  IL1 and TNF alpha induce cGMP formation in C6 astrocytoma cells via the nitridergic pathway. , 1993, Brain research.

[200]  S. Padmaja,et al.  The reaction of no with superoxide. , 1993, Free radical research communications.

[201]  H. Hartung,et al.  Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. , 1993, Journal of neuroimmunology.

[202]  M. L. Knapp,et al.  Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. , 1992, Clinical chemistry.

[203]  J S Beckman,et al.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. , 1992, Archives of biochemistry and biophysics.

[204]  A. Sher,et al.  Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[205]  M. Simmons,et al.  Induction of Nitric Oxide Synthase in Glial Cells , 1992, Journal of neurochemistry.

[206]  S. Abramson,et al.  Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. , 1992, The Journal of clinical investigation.

[207]  K. Boje,et al.  Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death , 1992, Brain Research.

[208]  H. Hartung,et al.  Production of nitrite by neonatal rat microglial cells/brain macrophages. , 1992, Cellular immunology.

[209]  J. Merrill,et al.  Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[210]  I. Rowland,et al.  Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide , 1992, Clinical and experimental immunology.

[211]  E. Hall Novel inhibitors of iron‐dependent lipid peroxidation for neurodegenerative disorders , 1992, Annals of neurology.

[212]  R. Wanders,et al.  Biochemistry of peroxisomes. , 1992, Annual review of biochemistry.

[213]  J. Newcombe,et al.  Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. , 1992, European neurology.

[214]  J. Stamler,et al.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[215]  B E Kendall,et al.  The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.

[216]  T. Cebula,et al.  DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. , 1991, Science.

[217]  Sherman Mp,et al.  Cytokine- and Pneumocystis carinii- induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. , 1991 .

[218]  S. Corradin,et al.  Phagocytosis enhances murine macrophage activation by interferon‐γ and tumor necrosis factor‐α , 1991 .

[219]  A. Bast,et al.  Oxidants and antioxidants: state of the art. , 1991, The American journal of medicine.

[220]  B. Freeman,et al.  Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. , 1991, Archives of biochemistry and biophysics.

[221]  W. Mcdonald,et al.  The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.

[222]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[223]  T. Billiar,et al.  Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. , 1991, The American journal of physiology.

[224]  Seung U. Kim,et al.  Oligodendroglial cell death induced by oxygen radicals and its protection by catalase , 1991, Journal of neuroscience research.

[225]  T. Nozaki,et al.  Trypanosoma cruzi: flow cytometric analysis of developmental stage differences in DNA. , 1991, The Journal of protozoology.

[226]  B. Freeman,et al.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.

[227]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[228]  H. Gruchow,et al.  Treatment of multiple sclerosis with hyperbaric oxygen. Results of a national registry. , 1991, Archives of neurology.

[229]  N. Otaki,et al.  [44] Detection of metallothionein in brain , 1991 .

[230]  N. Otaki,et al.  Detection of metallothionein in brain. , 1991, Methods in enzymology.

[231]  M. Sherman,et al.  Cytokine- and Pneumocystis carinii- induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. , 1991, The Journal of protozoology.

[232]  S. Corradin,et al.  Phagocytosis enhances murine macrophage activation by interferon-gamma and tumor necrosis factor-alpha. , 1991, European journal of immunology.

[233]  J. Connor,et al.  Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains , 1990, Journal of neuroscience research.

[234]  S. Thom,et al.  Carbon monoxide-mediated brain lipid peroxidation in the rat. , 1990, Journal of applied physiology.

[235]  R. Stocker,et al.  Selective degeneration of oligodendrocytes mediated by reactive oxygen species. , 1990, Free radical research communications.

[236]  M. Cuzner,et al.  Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma-treated microglia isolated from adult rat brain. , 1989, Immunology.

[237]  G. Wong,et al.  Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor , 1989, Cell.

[238]  J. Merrill,et al.  Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.

[239]  J. Connor,et al.  Do oligodendrocytes mediate iron regulation in the human brain? , 1989, Annals of neurology.

[240]  E. Hall,et al.  Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U74006F , 1988, Brain Research.

[241]  H. Hartung,et al.  Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase , 1988, Annals of neurology.

[242]  P. Lebon,et al.  Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions , 1988, Journal of the Neurological Sciences.

[243]  P. Doherty,et al.  Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen , 1988, Journal of Neuroimmunology.

[244]  P. Lebon,et al.  Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. , 1988, Journal of the neurological sciences.

[245]  A. Slivka,et al.  Histochemical evaluation of glutathione in brain , 1987, Brain Research.

[246]  R. Fine,et al.  Development of transferrin‐positive oligodendrocytes in the rat central nervous system , 1987, Journal of neuroscience research.

[247]  J. Clausen,et al.  Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis--effects of antioxidant supplementation. , 2009, Acta pharmacologica et toxicologica.

[248]  J. Haglin,et al.  Hyperbaric oxygenation and erythrocyte antioxidant enzymes in multiple sclerosis patients , 1986, Acta neurologica Scandinavica.

[249]  J. Gutteridge Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides , 1986, FEBS letters.

[250]  R. Wiggins,et al.  Effect of Reactive Oxygen Species on Myelin Membrane Proteins , 1985, Journal of neurochemistry.

[251]  P. Doherty,et al.  Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent , 1984, The Journal of experimental medicine.

[252]  W. I. McDonald,et al.  Spontaneous and evoked electrical discharges from a central demyelinating lesion , 1982, Journal of the Neurological Sciences.

[253]  G. Ellison,et al.  Abnormal glutamic acid metabolism in multiple sclerosis , 1980, Journal of the Neurological Sciences.

[254]  C. Schauf,et al.  Mechanical fragility of erythrocytes in multiple sclerosis , 1980, Neurology.

[255]  J. Prineas,et al.  Remyelination in multiple sclerosis , 1978, Annals of neurology.

[256]  M. Ginsberg Delayed neurological deterioration following hypoxia. , 1979, Advances in neurology.

[257]  E. Holtzman,et al.  Microperoxisomes in the central nervous system of the postnatal rat , 1978, Brain Research.

[258]  C. Thuning,et al.  Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents. , 1978, Journal of immunology.

[259]  J. Clausen,et al.  ERYTHROCYTE GLUTATHIONE PEROXIDASE DEFICIENCY IN MULTIPLE SCLEROSIS , 1977, Acta neurologica Scandinavica.

[260]  D. Metcalf,et al.  Cells in Culture , 1977 .

[261]  M. Ginsberg,et al.  Hypoxic-ischemic leukoencephalopathy in man. , 1976, Archives of neurology.

[262]  E. J. Field,et al.  Red blood cell fragility in multiple sclerosis. , 1967, British medical journal.